# Can Stem Cells Regenerate the Injured Brain? | Edward Chang, M.D.

**Channel:** Peter Attia MD
**Upload Date:** 2025-09-13
**URL:** https://www.youtube.com/watch?v=gwFP8sVgfDM
**Duration:** 6 minutes

## Description

Get An Introductory Guide to Longevity and my weekly newsletter here (free): https://bit.ly/3JKL1th
Watch the full episode:  https://youtu.be/y7LXTyUhSVM
Become a member to receive exclusive content: https://bit.ly/3VtUW9g

This clip is from episode  #363 ‒ A new frontier in neurosurgery: restoring brain function with brain-computer interfaces, advancing glioblastoma care, and new hope for devastating brain diseases | Edward Chang, M.D.

In this clip, they discuss:

- Renewed Interest – Advances in organoids and cell-based therapies are bringing new promise
- Targeted Replacement – First breakthroughs may come from restoring small, specific brain regions
- Parkinson’s Example – Stem cells could replace dopaminergic neurons
- Why Neurons Die – Genetic risk, environmental toxins, and unknown factors all contribute
- Next-Gen Therapies – Improved cell models, delivery methods, and immune management are being trialed

--------
About:

The Peter Attia Drive is a deep-dive podcast focusing on maximizing longevity, and all that goes into that from physical to cognitive to emotional health. With over 90 million episodes downloaded, it features topics including exercise, nutritional biochemistry, cardiovascular disease, Alzheimer’s disease, cancer, mental health, and much more.

Peter Attia is the founder of Early Medical, a medical practice that applies the principles of Medicine 3.0 to patients with the goal of lengthening their lifespan and simultaneously improving their healthspan. 

Learn more: https://peterattiamd.com

Connect with Peter on:
Facebook: http://bit.ly/PeterAttiaMDFB
Twitter: http://bit.ly/PeterAttiaMDTW
Instagram: http://bit.ly/PeterAttiaMDIG

Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify
Google Podcasts: http://bit.ly/TheDriveGoogle

Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information and the materials linked to this podcast is at the user's own risk. The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. I take conflicts of interest very seriously. For all of my disclosures and the companies I invest in or advise, please visit my website where I keep an up-to-date and active list of such companies. For a full list of our registered and unregistered trademarks, trade names, and service marks, please review our Terms of Use: https://peterattiamd.com/terms-of-use/

## AI Summary

Based on this transcript excerpt, I'll provide an analysis of the discussed content:

**1. Executive Summary**:
The episode features a discussion between Dr. Peter Attia and Dr. Edward Chang about stem cell therapy for brain regeneration, with a particular focus on Parkinson's disease treatment. The conversation explores both historical attempts and future possibilities of using stem cells to treat neurological conditions, highlighting both the challenges and potential breakthroughs in this field.

**2. Key Medical/Scientific Points**:
- Stem cell therapy for brain regeneration showed modest results 10-15 years ago [00:00:52]
- Parkinson's disease involves degeneration of dopaminergic neurons in the substantia nigra [00:01:22]
- Multiple causes of Parkinson's discussed: genetic predisposition, environmental toxins [00:02:04]
- Early fetal graph transplants were attempted 20-30 years ago with mixed results [00:02:36]
- Side effects of excess dopamine can cause dyskinesia (hyper-movement) [00:02:36]

**3. Health Optimization Tips**:
Universal Recommendations:
- None specifically mentioned in this excerpt

Context-specific recommendations:
- Careful monitoring of dopamine levels in Parkinson's treatment [00:02:36]

**4. Supplements & Medications**:
- Dopamine replacement medications mentioned for Parkinson's [00:02:04]

**5. Exercise & Movement**:
- Bradykinesia (slow movement) discussed as a Parkinson's symptom [00:02:36]

**7. Biomarkers & Testing**:
- Dopamine levels mentioned as crucial for treatment monitoring [00:02:36]

**8. References & Resources**:
Expert mentioned:
- Dr. Edward Chang, discussing stem cell therapy and brain regeneration
- UCSF mentioned regarding new therapeutic approaches [00:03:29]

**9. Notable Quotes**:
"It's not as simple as just putting them in there. They actually have to be tuned in the right way to put out the right levels." [00:02:36]

**10. Follow-up Questions**:
1. What are the latest developments in synthetic cell technology for neurological conditions?
2. How have immunosuppression protocols evolved for neural stem cell transplants?
3. What are the specific delivery systems being developed for stem cell therapy?
4. What is the current status of organoid research for brain regeneration?

Note: Some sections were omitted as they weren't addressed in the provided transcript excerpt.

## Transcript

[00:00:00] So many people suffer brain injuries and if you could wave a magic wand, you would just hope for some regeneration of the injured portion of her brain. And my guess is in the case of an the actual total volume of cells that are damaged is quite small. It could be this, you know, half the size of your thumb, right? I mean, it's a relatively small, but it just happened to be in the most precious part of real estate in her entire body.

[00:00:27] So, do we know or do you have any point of view on the potential future of stem cell-like interventions for the purpose of uh regeneration specifically in the CNS? Yeah, I mean this is an area that I think got a lot of focus and attention maybe about 10 or 15 years ago and I would say largely the results were pretty modest.

[00:00:52] Yeah, at best. Um, yeah, at best. Um it's coming back now because of a lot of cell-based therapies, organoids, um building miniature models of brains, um on cell cultures basically. Um I think the first things that we're going to see and where I am seeing some promise is uh very focal delivery in replacing cells that have been lost in small targets of the brain. So back to

[00:01:22] Parkinson's disease where you've got degeneration of dopamineergic neurons and the substantia the goal is can you replace and basically transplant some stem cells into that part of the brain um and remind me why the cells in the substantionigra go is it an autoimmune like what do we know what's killing them um I think there's a lot of um a lot of information it could be multiple fold it's partly genetic Um there are certain genes that predispose to degeneration there. Um there's certain environmental toxins that can cause the degeneration and then there's like a huge bucket like we still don't know you know what's causing that.

[00:02:04] Um but at the end of the day there is a degeneration of those very specialized cells. Most of the treatments are around dopamine replacement medications. And how close do you think we are towards um transplant? Well um it's already been done. actually like 20 30 years ago. Oh really? I wasn't using fetal uh graphs and they just didn't take um some of them took and in fact um patients some patients got benefit from it. The side effects were also fairly severe. Um there were a variety of different reasons.

[00:02:36] What kind of side effects? Um like if you have too much dopamine you can actually get disanas. So hyper movement. So Parkinson one of the cardinal symptoms of Parkinson's hypo movement. Yeah. Yeah. uh bradicinesia specifically uh where you have slowed movements, slow to initiate movements as well. Um but if you have cells that are just pumping out dopamine, they can also be putting out too much and you get the opposite effect. So it's not as simple as just putting them in there. They actually have to be tuned Yeah. in the right way to put out the right levels. And so there's a new generation of new therapies that uh we're really interested in triing UCSF um that are much better cell models, much better control of dopamine that's involved. We have much better delivery systems to make sure that the distribution and and um I mean could you imagine that? Could you imagine engineering your way out of

[00:03:29] Parkinson's disease? We're working on it. What about synthetic cells where you completely get to control it, right? So again, you have the substrate problem, but if it's truly a synthetic cell, then presumably it can make dopamine as well. I mean, as opposed to an implantable sort of slow leak dopamine that you come up with some slick way to refill, but um what do you think is more likely kind of the the more pure engineering approach or the more biologic transplant approach where you just try to tune it?

[00:03:59] Uh the near-term of course is taking some cell cultures that are not like purely synthesized. That still I think is a huge goal outside of just brain like can you generate a cell denovo um without some does that require immune uh modulation? Oh absolutely. So it's a full transplant. Yeah. So a lot of these patients uh initially will be on imunosuppression for that but that's also improved a lot.

[00:04:27] Yeah. Right. Like that's just as immunosuppressive as if they had a kidney transplant or a liver or heart transplant. Yes. Wow. Yeah, but I think that's primarily right now at the level of precaution, you know, and there is progress being made in trying to make these things um as least immunogenic as possible.

[00:04:47] Um and that that's where a lot of the engineering actually is focused on is just make it um like the least amunogenic um to avoid a rejection scenario. So I am excited about that and that's some of the biological engineering that I was talking about like biotechnology or the future of technology be really coming back to the biology moving a little bit away from the uh electrical engineering.

[00:05:14] What do you think the world looks like in 2040? Which major problems that stand in front of you today do you expect to fall and what will be the implications? I'm Peter Aia. This podcast relies exclusively on premium subscribers for support, which allows us to provide all our content without taking a single penny from advertisers. I believe this keeps my content honest, making it a trusted resource for listeners like you.

[00:05:46] As a premium member, you'll get immediate access to our entire back catalog of AMA episodes and all future AMA episodes. You'll get longevity focused premium articles packed with actionable insights. You'll get unrivaled show notes for each and every episode of The Drive. Every topic, every study, every resource from each episode carefully curated for you. You'll get quarterly podcast summaries where you'll learn my biggest personal takeaways from the previous 90 days of expert guest episodes and much more. This journey doesn't have to be navigated alone. We can take these steps towards a better, longer life together. Become a premium member today at peterati md.com/subscribe to join me in a shared commitment to a healthier future.

[00:06:47] [Music]